Evaluating Innovation in the Pharmaceutical Industry

Returns to innovation constitute a major component of social welfare. To evaluate innovations and their diffusion over time, requires use of a methodology that isolates their precise effect on welfare. This is particularly important in the pharmaceutical industry where rapid innovation occurs and drug development costs are high. In this study, I formulate… CONTINUE READING